→ Macrocytic RBCs!vitamin B12 or folate deficiency → Microcytic RBCs! iron deficiency anemia: results from acute/chronic blood loss, insufficient intake or in heavily menstruating/pregnant women → Normocytic RBCs! acute blood loss & hemolysis → Iron is stored as ferritin in intestinal mucosal cells → Phlebotomy → for chronic iron overload without anemia → Vitamin B12!cofactor for many rxns; deficiency!microcytic megaloblastic anemia and neurologic abnormalities o Ultimate source: microbial synthesis!not synthesized by plants or animals (found in meat, eggs and dairy) o stored in the liver; would take about 5 years to develop the anemia from depleting stores requires R Factor & Intrinsic Factor review o absorbed only after its formed a complex w/ intrinsic factor in the distal ileum via receptor-mediated transport system notes o deficiency results from malabsorption d/t lack of IF (pernicious anemia) or defective transporter or d/t nutritional deficiency as seen in strict vegetarians, partial or total gastrectomy and any condition that affects the distal ileum o deficiency prevents synthesis of purines required for DNA synthesis & chronic pancreatitis: cannot cleave RF-B12 complex o deficiency causes accumulation of homocysteine and methylmalonyl-CoA o SXS include neurologic syndrome!paresthesia in peripheral nerves, weakness and progresses to spasticity, ataxia and other CNS dysfxn o admin of folic acid will NOT prevent neurologic SXS even though it will correct the anemia → Folic acid! cofactor for many rxns; deficiency!microcytic megaloblastic anemia o Deficiency can develop within 1-6mon after intake has stopped :fast depletion of stores o deficiency prevents synthesis of purines required for DNA synthesis dUMP --> dTMP o deficiency causes accumulation of homocysteine o deficiency is often caused by inadequate dietary intake (alcoholics and liver disease), increased demand (pregnant women, pts with hemolytic anemia), malabsorption syndromes affecting the jejunum, or certain drugs (methotrexate, trimethoprim and pyrimethamine or long term therapy with phenytoin) ** phenytoin does not cause megaloblastic changes Drug Name Class Description Uses Pharmacodynamics Adverse effects /Contraindications Nausea Ferrous Sulfate Iron deficiency anemia!hypochromic microcytic anemia Epigastric discomfort Ferrous gluconate Oral iron therapy Abdominal cramps Ferrous iron is most Ferrous fumarate TXT should continue 3-6mon after correction of the cause of the iron loss Constipation Iron efficiently absorbed!only Diarrhea preparations ferrous salts should be Iron deficiency anemia!hypochromic microcytic anemia used Iron dextran
Sodium ferric gluconate complex Parenteral iron therapy Reserved for pts who can’t tolerate oral iron or in pts w/ chronic anemia who Iron sucrose can’t be maintained on oral iron alone Acute Iron Toxicity: seen in young children who ingest iron pills!necrotizing Deferoxamine gastroenteritis with vomiting, abdominal pain, and bloody diarrhea followed by shock, metabolic acidosis coma and death Binds to iron which has Chronic Iron Toxicity/Hemochromatosis: XS iron is deposited in the heart, already been absorbed! Iron chelator Given parentally liver, pancreas, etc.!organ failure and death; seen in pts with inherited promotes excretion in hemochromatosis or pts receiving many red cell transfusions (thalassemia Deferasirox urine and feces major pts) & sickle cell disease Acute Iron Toxicity Therapy must be continued for life in Vitamin B12 deficiency! megaloblastic, macrocytic anemia Two reactions: pts with pernicious anemia Cyanocobalamin homocysteine → Parenteral Vitamin B12 Hydroxocobalamin Hydroxocobalamin preferred b/c it is more highly protein-bound and this methionine Deficiency of cobalamin can cause Vitamins (inactive) activated to: remains longer in circulation methylmalonyl → succinyl neurologic abnormalities due to (macrocytic) • dihydroacetylcobalamin? (Methylmalonyl CoA path) • methylcobalamin (methionine pathway) increased homocysteine Folic acid deficiency and B12 deficiency Required for purine Deficiency is a lot more common than Masking of neurologic deficits in B12 Folic Acid Prevents neural tube defects (spina bifida) in the fetus when given to a synthesis Need B12 to form B12, but can be easily corrected deficiency pregnant woman THF → folate trap Stimulates erythroid proliferation and • Chronic Renal Disease (intrinsic low EPO) differentiation via JAK/STAT Produced in the kidney in Erythropoietin • cannot be used if extra-renal anemia (EPO normal) cytokine receptor Anemia with renal disease [can’t produce endogenous EPO → best response to hypoxia Hyperviscosity → HTN & thrombosis Induces release of reticulocytes from BM responders] • MI 3x Longer acting than EPO ↓clearance in comparison • stroke Darbepoetin Hematopoietic Two CHO chains to erythropoietin Growth Filgrastim (G-CSF)! production/fxn of neutrophils Myeloid growth factors with JAK/STAT C-CSF!bone pain Factors Sargramostin (GM-CSF)! production/fxn of neutrophils +production of other Filgrastim G-CSF receptors GM-CSF! fever, arthralgia, and myeloid megakaryocyte progenitors Sargramostin GM-CSF capillary damage with edema patients with (cytokine receptor) Allergic rxns=rare BM supression Primary and secondary neutropenia; after cancer chemotherapy along with Txt of pts with prior episode of thrombocytopenia after chemo IL-11 Megakaryocyte growth factor : platelets thrombopoeitin Reduced need for platelet transfusions Sickle cell Anemia + folate supplements Sickle cell Increases fetal Hb!dilute HbS!relieve Bone marrow suppression aplastic Hydroxyurea Chronic myelogenous leukemia Agents painful crisis (less hypoxia) Cutaneous vasculitis crisis Polycythemia Vera